Skip to main content
. 2017 Aug 24;4:38. doi: 10.3389/fnut.2017.00038

Table 4.

Mediterranean diet (MD) components and development of prostate cancer.

Reference Characteristics of the studies Sample size Risk of prostate cancer
Bosetti et al. (35) Case–control study 1,294 cases and 1,451 controls Odds ratio (OR) = 1.15 (95% CI = 0.90–1.46, p = 0.03) for highest vs lowest quintiles of milk or dairy products intake
OR = 1.38 (95% CI = 1.03–1.83, p = 0.01) for highest vs lowest quintiles of bread intake
OR = 0.77 (95% CI = 0.59–0.99, p = 0.02) for highest vs lowest quintiles of soups intake
OR = 0.74 (95% CI = 0.57–0.95, p = 0.01) for highest vs lowest quintiles of cooked vegetables intake

Turati et al. (69) Meta-analysis from case–control studies 1.294 prostate cancer cases from 10,796 cases of different cancers and 17,000 controls OR = 0.87 (95% CI = 0.70–1.09) for highest intake of cruciferous vegetables
OR = 0.29 (95% CI = 0.07–1.03) for highest intake of onions
OR = 0.81 (95% CI = 0.64–1.00) for highest intake of garlic
OR = 0.91 (95% CI = 0.77–1.07) for highest intake of apples
OR = 0.87 (95% CI = 0.76–0.99) for highest intake of proanthocyanidins

Schwingshackl and Hoffmann (12) Meta-analysis from 21 cohort studies and 12 case–control studies 29,867 prostate cancer cases from a total number of 1,431,461 subjects RR: 0.96 (95% CI = 0.92–0.99, p = 0.03) for high adherence to the MD

Psaltopoulou et al. (72) Systematic review and meta-analysis from 19 observational studies 13,800 patients and 23,340 controls from overall studies; 1,495 prostate cancer cases and 1,631 controls from three case–control studies OR: 0.53 (95% CI = 0.30–0.94, p = 0.03) for high content of vitamin E in olive oil

Key et al. (75) Meta-analysis from 15 case–control studies 11,239 prostate cancer cases and 18,541 controls Total prostate cancer: OR = 1.13 (95% CI = 1.04–1.22, p = 0.015) for highest vs lowest quintiles of retinol intake
OR = 0.86 (95% CI = 0.78–0.94, p < 0.001) for highest vs lowest quintiles of α-tocopherol intake
Advanced prostate cancer: OR = 0.71 (95% CI = 0.57–0.88, p = 0.019) for 80% increase of α-tocopherol
OR = 0.73 (95% CI = 0.54–0.99, p = 0.036) for 80% increase of lycopene
Aggressive prostate cancer: OR = 0.70 (95% CI = 0.58–0.86, p = 0.014) for 80% increase of α-tocopherol
OR = 0.72 (95% CI = 0.53–0.97, p = 0.025) for 80% increase of lycopene

Gann et al. (77) Case–control study 578 prostate cancer cases and 1,294 controls Aggressive prostate cancer: unadjusted OR = 0.56 (95% CI = 0.34–0.92, p = 0.02) for highest concentration of lycopene
OR = 0.40 (95% CI = 0.19–0.84, p = 0.006) for highest vs lowest plasma levels of lycopene